PT-141 serves as a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound operates by activating specific receptors throughout the body, causing to improved sexual response. Research studies have suggested that PT-141 has the potential to effectively manage a variety of sexual